Melanomas arising in the uveal tract of the eye are a rare form of the disease with a biology
and clinical phenotype distinct from their more common cutaneous counterparts. Treatment …

Deubiquitinases (DUBs) are emerging as important regulators of many pathways germane
to cancer. They may regulate the stability of key oncogenes, exemplified by USP28 …

Background Uveal melanoma is a disease that is distinct from cutaneous melanoma, with a
low tumor mutational burden and a 1-year overall survival of approximately 50% in patients …

In patients with previously treated metastatic uveal melanoma, the historical 1 year overall
survival rate is 37% with a median overall survival of 7.8 months. We conducted a multicenter, …

The majority of chemotherapy drugs are dosed based on body surface area (BSA). No
standard BSA values for patients being treated in the United Kingdom are available on which to …

Background Tebentafusp, a T-cell receptor–bispecific molecule that targets glycoprotein
100 and CD3, is approved for adult patients who are positive for HLA-A*02:01 and have …

Importance Large cohorts of patients with active cancers and COVID-19 infection are needed
to provide evidence of the association of recent cancer treatment and cancer type with …

Immunotherapy using immune checkpoint inhibitors (ICIs) induces durable responses in
many metastatic cancers. Metastatic uveal melanoma (mUM), typically occurring in the liver, is …

Phosphoinositide 3-kinase δ (PI3Kδ) has a key role in lymphocytes, and inhibitors that
target this PI3K have been approved for treatment of B cell malignancies 1 , 2 – 3 . Although …

PURPOSE This phase I study aimed to define the recommended phase II dose (RP2D) of
tebentafusp, a first-in-class T-cell receptor/anti-CD3 bispecific protein, using a three-week step-…